New policy: MP.PA.104
Aug. 2023Important Notices
Effective Sept. 15, 2023, UPMC Health Plan will implement a new medical policy: Elective Percutaneous Coronary Intervention (PCI) – MP.PA.104. This is a change from the previously communicated effective date of Sept. 1, 2023, as posted in the August issue of Provider Partner Update. This policy will require prior authorization of PCI services to be considered for reimbursement. View more information on MP.PA.104.
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars